IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JESSICA HELLYER

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1235557398
CMS profile
7228712
Location
PHILADELPHIA, PA

General Payments · PY2019–2024

$12,675.58

  • Reported across 59 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$11,516.11

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Medical Oncology PA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $10,375.00 8
Food and Beverage $1,141.11 43

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Tempus AI, Inc $10,531.95 11
Acerta Pharma LLC $294.85 8
NOVARTIS PHARMACEUTICALS CORPORATION $135.44 6
E.R. Squibb & Sons, L.L.C. $95.32 5
Takeda Pharmaceuticals U.S.A., Inc. $69.01 3
Incyte Corporation $66.13 3
Janssen Biotech, Inc. $62.56 3
Mirati Therapeutics, Inc. $52.76 2
Merck Sharp & Dohme Corporation $45.62 2
AVEO Pharmaceuticals, Inc. $29.27 1
Blueprint Medicines Corporation $23.74 1
ARRAY BIOPHARMA INC $21.22 1
Fennec Pharmaceuticals, Inc. $20.66 1
PUMA BIOTECHNOLOGY, INC. $19.78 1
Genentech USA, Inc. $19.12 1
Regeneron Healthcare Solutions, Inc. $15.60 1
Gilead Sciences, Inc. $13.08 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $500.00 1
PY2021 $500.00 1
PY2022 $94.53 2
PY2023 $64.94 4
PY2024 $11,516.11 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2019202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ARRAY BIOPHARMA INC $21.22 10/16/2024 Food and Beverage Undisputed 01/23/2026 1132134505 CMS
AstraZeneca Pharmaceuticals LP $29.19 06/05/2024 Food and Beverage Undisputed 01/23/2026 1104723155 CMS
AstraZeneca Pharmaceuticals LP $27.20 06/25/2024 Food and Beverage Undisputed 01/23/2026 1105224315 CMS
AstraZeneca Pharmaceuticals LP $25.59 07/29/2024 Food and Beverage Undisputed 01/23/2026 1105405151 CMS
AstraZeneca Pharmaceuticals LP $14.26 07/30/2024 Food and Beverage Undisputed 01/23/2026 1104666721 CMS
AstraZeneca Pharmaceuticals LP $20.72 08/21/2024 Food and Beverage Undisputed 01/23/2026 1104264163 CMS
AstraZeneca Pharmaceuticals LP $124.99 10/02/2024 Food and Beverage Undisputed 01/23/2026 1104674853 CMS
AstraZeneca Pharmaceuticals LP $28.49 11/16/2024 Food and Beverage Undisputed 01/23/2026 1105304983 CMS
AstraZeneca Pharmaceuticals LP $24.41 12/18/2024 Food and Beverage Undisputed 01/23/2026 1104230357 CMS
Aveo Pharmaceuticals, Inc. $29.27 11/07/2024 Food and Beverage Undisputed 01/23/2026 1143479656 CMS
Blueprint Medicines Corporation $23.74 12/18/2024 Food and Beverage Undisputed 01/23/2026 1147448916 CMS
E.R. Squibb & Sons, L.L.C. $18.26 04/25/2024 Food and Beverage Undisputed 01/23/2026 1101231059 CMS
E.R. Squibb & Sons, L.L.C. $15.78 06/20/2024 Food and Beverage Undisputed 01/23/2026 1101231067 CMS
E.R. Squibb & Sons, L.L.C. $19.28 09/12/2024 Food and Beverage Undisputed 01/23/2026 1101231083 CMS
E.R. Squibb & Sons, L.L.C. $14.97 09/28/2024 Food and Beverage Undisputed 01/23/2026 1101231089 CMS
E.R. Squibb & Sons, L.L.C. $27.03 12/19/2024 Food and Beverage Undisputed 01/23/2026 1101231093 CMS
Fennec Pharmaceuticals, Inc. $20.66 10/30/2024 Food and Beverage Undisputed 01/23/2026 1120185446 CMS
Genentech USA, Inc. $19.12 10/23/2024 Food and Beverage Undisputed 01/23/2026 1133032312 CMS
Gilead Sciences, Inc. $13.08 04/11/2024 Food and Beverage Undisputed 01/23/2026 1133833636 CMS
Incyte Corporation $20.45 07/30/2024 Food and Beverage Undisputed 01/23/2026 1141231443 CMS
Incyte Corporation $27.03 08/20/2024 Food and Beverage Undisputed 01/23/2026 1141231067 CMS
Incyte Corporation $18.65 11/13/2024 Food and Beverage Undisputed 01/23/2026 1141169437 CMS
Janssen Biotech, Inc. $16.71 03/19/2024 Food and Beverage Undisputed 01/23/2026 1078582960 CMS
Janssen Biotech, Inc. $27.39 07/25/2024 Food and Beverage Undisputed 01/23/2026 1078584446 CMS
Janssen Biotech, Inc. $18.46 12/04/2024 Food and Beverage Undisputed 01/23/2026 1078587696 CMS
Merck Sharp & Dohme LLC $14.77 09/26/2024 Food and Beverage Undisputed 01/23/2026 1141781099 CMS
Merck Sharp & Dohme LLC $30.85 10/17/2024 Food and Beverage Undisputed 01/23/2026 1141897490 CMS
Mirati Therapeutics, Inc. $16.65 06/11/2024 Food and Beverage Undisputed 01/23/2026 1117160828 CMS
Mirati Therapeutics, Inc. $36.11 11/18/2024 Food and Beverage Undisputed 01/23/2026 1117160824 CMS
Novartis Pharmaceuticals Corporation $20.72 05/21/2024 Food and Beverage Undisputed 01/23/2026 1086946949 CMS
Novartis Pharmaceuticals Corporation $8.01 05/21/2024 Food and Beverage Undisputed 01/23/2026 1086946973 CMS
Novartis Pharmaceuticals Corporation $28.70 07/17/2024 Food and Beverage Undisputed 01/23/2026 1086946967 CMS
Novartis Pharmaceuticals Corporation $33.40 09/18/2024 Food and Beverage Undisputed 01/23/2026 1086946981 CMS
Novartis Pharmaceuticals Corporation $19.56 11/19/2024 Food and Beverage Undisputed 01/23/2026 1086946989 CMS
Novartis Pharmaceuticals Corporation $25.05 11/20/2024 Food and Beverage Undisputed 01/23/2026 1086946985 CMS
PUMA BIOTECHNOLOGY, INC. $19.78 10/18/2024 Food and Beverage Undisputed 01/23/2026 1113837250 CMS
Regeneron Healthcare Solutions, Inc. $15.60 10/02/2024 Food and Beverage Undisputed 01/23/2026 1114067715 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15.88 08/06/2024 Food and Beverage Undisputed 01/23/2026 1144958944 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.81 09/24/2024 Food and Beverage Undisputed 01/23/2026 1144958946 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.32 11/06/2024 Food and Beverage Undisputed 01/23/2026 1144958948 CMS
Tempus AI, Inc $1,500.00 02/29/2024 Consulting Fee Undisputed 01/23/2026 1150166160 CMS
Tempus AI, Inc $1,875.00 02/29/2024 Consulting Fee Undisputed 01/23/2026 1150166162 CMS
Tempus AI, Inc $57.69 05/17/2024 Food and Beverage Undisputed 01/23/2026 1150166164 CMS
Tempus AI, Inc $95.75 05/21/2024 Food and Beverage Undisputed 01/23/2026 1150166166 CMS
Tempus AI, Inc $500.00 08/30/2024 Consulting Fee Undisputed 01/23/2026 1150166168 CMS
Tempus AI, Inc $1,500.00 08/30/2024 Consulting Fee Undisputed 01/23/2026 1150166170 CMS
Tempus AI, Inc $1,250.00 08/30/2024 Consulting Fee Undisputed 01/23/2026 1150166172 CMS
Tempus AI, Inc $2,250.00 08/30/2024 Consulting Fee Undisputed 01/23/2026 1150166174 CMS
Tempus AI, Inc $750.00 08/30/2024 Consulting Fee Undisputed 01/23/2026 1150166176 CMS
Tempus AI, Inc $750.00 10/15/2024 Consulting Fee Undisputed 01/23/2026 1150166178 CMS
Tempus AI, Inc $3.51 10/22/2024 Food and Beverage Undisputed 01/23/2026 1150166180 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.